Coronary Endothelial Dysfunction Induced by Nucleotide Oligomerization Domain-Like Receptor Protein with Pyrin Domain Containing 3 Inflammasome Activation during Hypercholesterolemia: Beyond Inflammation

Antioxidants and Redox Signaling

Volumn 22, Issue 13, 2015, Pages 1084-1096

  Zhang, Yang ^a   Li, Xiang ^a   Pitzer, Ashley L ^a   Chen, Yang ^a   Wang, Lei ^a   Li, Pin Lan ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; BRADYKININ; CHOLESTEROL; CRYOPYRIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HIGH MOBILITY GROUP B1 PROTEIN; INFLAMMASOME; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR; PROTEIN INHIBITOR; RECOMBINANT PROTEIN; SUPEROXIDE; CARRIER PROTEIN; CELL SURFACE RECEPTOR; CIAS1 PROTEIN, MOUSE; CYTOSKELETON PROTEIN; GLYCYRRHIZIC ACID; INTERLEUKIN-1BETA-CONVERTING ENZYME INHIBITOR; MARENOSTRIN; NITRIC OXIDE; NUCLEOTIDE; POLOXAMER; REACTIVE OXYGEN METABOLITE; SERINE PROTEINASE INHIBITOR; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DOWN REGULATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVITY; HYPERCHOLESTEROLEMIA; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYROPTOSIS; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; CORONARY BLOOD VESSEL; DISEASE MODEL; DRUG EFFECTS; INFLAMMATION; METABOLISM; PATHOLOGY; VASODILATATION;

MUS;

ACETYLCHOLINE; ANIMALS; BRADYKININ; CARRIER PROTEINS; CASPASE 1; CHOLESTEROL; CORONARY VESSELS; CYTOSKELETAL PROTEINS; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; GLYCYRRHIZIC ACID; HMGB1 PROTEIN; HYPERCHOLESTEROLEMIA; INFLAMMASOMES; INFLAMMATION; MALE; MICE, INBRED C57BL; NITRIC OXIDE; NUCLEOTIDES; POLOXAMER; PYROPTOSIS; REACTIVE OXYGEN SPECIES; RECEPTORS, CELL SURFACE; SERPINS; SUPEROXIDES; VASODILATION; VIRAL PROTEINS;

EID: 84934268395     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2014.5978     Document Type: Article

References (58)

1. Baumer Y, Meiler S, Anastasiadis P, Allen J, and Boisvert WA. Cholesterol crystals of atherosclerotic lesions induce endothelial dysfunction via RhoA activation. FASEB J 26: 991.8, 2012.
2. Becker KA, Henry B, Ziobro R, Tummler B, Gulbins E, and Grassme H. Role of CD95 in pulmonary inflammation and infection in cystic fibrosis. J Mol Med (Berl) 90: 1011-1023, 2012.
3. Bleda S, de Haro J, Varela C, Esparza L, Ferruelo A, and Acin F. NLRP1 inflammasome, and not NLRP3, is the key in the shift to proinflammatory state on endothelial cells in peripheral arterial disease. Int J Cardiol 172: e282-e284, 2014.
4. Boini KM, Xia M, Abais JM, Li G, Pitzer AL, Gehr TW, Zhang Y, and Li PL. Activation of inflammasomes in podocyte injury of mice on the high fat diet: effects of ASC gene deletion and silencing. Biochim Biophys Acta 1843: 836-845, 2014.
5. Boini KM, Xia M, Abais JM, Xu M, Li CX, and Li PL. Acid sphingomyelinase gene knockout ameliorates hyperhomocysteinemic glomerular injury in mice lacking cystathionine-beta-synthase. PLoS One 7: e45020, 2012.
6. Boini KM, Xia M, Li C, Zhang C, Payne LP, Abais JM, Poklis JL, Hylemon PB, and Li PL. Acid sphingomyelinase gene deficiency ameliorates the hyperhomocysteinemiainduced glomerular injury in mice. Am J Pathol 179: 2210-2219, 2011.
7. Busso N and So A. Mechanisms of inflammation in gout. Arthritis Res Ther 12: 206, 2010.
8. Chen GY and Nunez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 10: 826-837, 2010.
9. Dinarello CA, Donath MY, and Mandrup-Poulsen T. Role of IL-1beta in type 2 diabetes. Curr Opin Endocrinol Diabetes Obes 17: 314-321, 2010.
10. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nunez G, Schnurr M, Espevik T, Lien E, Fitzgerald KA, Rock KL, Moore KJ, Wright SD, Hornung V, and Latz E. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464: 1357-1361, 2010.
11. Fearon WF and Fearon DT. Inflammation and cardiovascular disease: role of the interleukin-1 receptor antagonist. Circulation 117: 2577-2579, 2008.
12. Fu X, Huang X, Li P, Chen W, and Xia M. 7-Ketocholesterol inhibits isocitrate dehydrogenase 2 expression and impairs endothelial function via microRNA-144. Free Radic Biol Med 71: 1-15, 2014.
13. Gill PS and Wilcox CS. NADPH oxidases in the kidney. Antioxid Redox Signal 8: 1597-1607, 2006.
14. Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, Fitzgerald KA, Latz E, Moore KJ, and Golenbock DT. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 9: 857-865, 2008.
15. Hu J, Zhu Q, Xia M, Guo TL, Wang Z, Li PL, Han WQ, Yi F, and Li N. Transplantation of mesenchymal stem cells into the renal medulla attenuated salt-sensitive hypertension in Dahl S rat. J Mol Med 92: 1139-1145, 2014.
16. Imaeda AB, Watanabe A, Sohail MA, Mahmood S, Mohamadnejad M, Sutterwala FS, Flavell RA, and Mehal WZ. Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. J Clin Invest 119: 305-314, 2009.
17. Jiang F. NADPH oxidase in the kidney: a Janus in determining cell fate. Kidney Int 75: 135-137, 2009.
18. Jin S, Yi F, Zhang F, Poklis JL, and Li PL. Lysosomal targeting and trafficking of acid sphingomyelinase to lipid raft platforms in coronary endothelial cells. Arterioscler Thromb Vasc Biol 28: 2056-2062, 2008.
19. Johnston TP, Jaye M, Webb CL, Krawiec JA, Alom-Ruiz SP, Sachs-Barrable K, and Wasan KM. Poloxamer 407 (P- 407)-mediated reduction in the gene expression of ATPbinding- cassette transporter A1 may contribute to increased cholesterol in peripheral tissues of P-407-treated rats. Eur J Pharmacol 536: 232-240, 2006.
20. Leon C, Wasan KM, Sachs-Barrable K, and Johnston TP. Acute P-407 administration to mice causes hypercholesterolemia by inducing cholesterolgenesis and down-regulating low-density lipoprotein receptor expression. Pharm Res 23: 1597-1607, 2006.
21. Li CX, Xia M, Han WQ, Li XX, Zhang C, Boini KM, Liu XC, and Li PL. Reversal by growth hormone of homocysteine- induced epithelial-to-mesenchymal transition through membrane raft-redox signaling in podocytes. Cell Physiol Biochem 27: 691-702, 2011.
22. Li X, Han WQ, Boini KM, Xia M, Zhang Y, and Li PL. TRAIL death receptor 4 signaling via lysosome fusion and membrane raft clustering in coronary arterial endothelial cells: evidence from ASM knockout mice. J Mol Med (Berl) 91: 25-36, 2013.
23. Li X, Xu M, Pitzer AL, Xia M, Boini KM, Li PL, and Zhang Y. Control of autophagy maturation by acid sphingomyelinase in mouse coronary arterial smooth muscle cells: protective role in atherosclerosis. J Mol Med (Berl) 92: 473-485, 2014.
24. Mariathasan S, Newton K, Monack DM, Vucic D, French DM, Lee WP, Roose-Girma M, Erickson S, and Dixit VM. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430: 213-218, 2004.
25. Martinon F, Mayor A, and Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol 27: 229-265, 2009.
26. Martinon F, Petrilli V, Mayor A, Tardivel A, and Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440: 237-241, 2006.
27. Miao EA, Rajan JV, and Aderem A. Caspase-1-induced pyroptotic cell death. Immunol Rev 243: 206-214, 2011.
28. Mohamed IN, Hafez SS, Fairaq A, Ergul A, Imig JD, and El-Remessy AB. Thioredoxin-interacting protein is required for endothelial NLRP3 inflammasome activation and cell death in a rat model of high-fat diet. Diabetologia 57: 413-423, 2014.
29. Rajamaki K, Lappalainen J, Oorni K, Valimaki E, Matikainen S, Kovanen PT, and Eklund KK. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS One 5: e11765, 2010.
30. Rathinam VA, Vanaja SK, and Fitzgerald KA. Regulation of inflammasome signaling. Nat Immunol 13: 333-342, 2012.
31. Ritter JK, Li C, Xia M, Poklis JL, Lichtman AH, Abdullah RA, Dewey WL, and Li PL. Production and actions of the anandamide metabolite prostamide E2 in the renal medulla. J Pharmacol Exp Ther 342: 770-779, 2012.
32. Rodriguez G, Mago N, and Rosa F. [Role of inflammation in atherogenesis]. Invest Clin 50: 109-129, 2009.
33. Rosin DL and Okusa MD. Dangers within: DAMP responses to damage and cell death in kidney disease. J Am Soc Nephrol 22: 416-425, 2011.
34. Sagulenko V, Thygesen SJ, Sester DP, Idris A, Cridland JA, Vajjhala PR, Roberts TL, Schroder K, Vince JE, Hill JM, Silke J, and Stacey KJ. AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC. Cell Death Differ 20: 1149-1160, 2013.
35. Savage CD, Lopez-Castejon G, Denes A, and Brough D. NLRP3-inflammasome activating DAMPs stimulate an inflammatory response in glia in the absence of priming which contributes to brain inflammation after injury. Front Immunol 3: 288, 2012.
36. Skrha J, Jr., Kalousova M, Svarcova J, Muravska A, Kvasnicka J, Landova L, Zima T, and Skrha J. Relationship of soluble RAGE and RAGE ligands HMGB1 and EN-RAGE to endothelial dysfunction in type 1 and type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 120: 277-281, 2012.
37. Stienstra R, Tack CJ, Kanneganti TD, Joosten LA, and Netea MG. The inflammasome puts obesity in the danger zone. Cell Metab 15: 10-18, 2012.
38. Strowig T, Henao-Mejia J, Elinav E, and Flavell R. Inflammasomes in health and disease. Nature 481: 278-286, 2012.
39. Teng B, Ansari HR, Oldenburg PJ, Schnermann J, and Mustafa SJ. Isolation and characterization of coronary endothelial and smooth muscle cells from A1 adenosine receptor- knockout mice. Am J Physiol Heart Circ Physiol 290: H1713-H1720, 2006.
40. Ventura E, Durant R, Jaussent A, Picot MC, Morena M, Badiou S, Dupuy AM, Jeandel C, and Cristol JP. Homocysteine and inflammation as main determinants of oxidative stress in the elderly. Free Radic Biol Med 46: 737-744, 2009.
41. Wei YM, Li X, Xiong J, Abais JM, Xia M, Boini KM, Zhang Y, and Li PL. Attenuation by statins of membrane raft-redox signaling in coronary arterial endothelium. J Pharmacol Exp Ther 345: 170-179, 2013.
42. Wei YM, Li X, Xu M, Abais JM, Chen Y, Riebling CR, Boini KM, Li PL, and Zhang Y. Enhancement of autophagy by simvastatin through inhibition of Rac1-mTOR signaling pathway in coronary arterial myocytes. Cell Physiol Biochem 31: 925-937, 2013.
43. Wen H, Ting JP, and O'Neill LA. A role for the NLRP3 inflammasome in metabolic diseases - did Warburg miss inflammation? Nat Immunol 13: 352-357, 2012.
44. Xia M, Boini KM, Abais JM, Xu M, Zhang Y, and Li PL. Endothelial NLRP3 inflammasome activation and enhanced neointima formation in mice by adipokine visfatin. Am J Pathol 184: 1617-1628, 2014.
45. Xia M, Conley SM, Li G, Li PL, and Boini KM. Inhibition of Hyperhomocysteinemia-induced inflammasome activation and glomerular sclerosis by NLRP3 gene deletion. Cell Physiol Biochem 34: 829-841, 2014.
46. Xia M, Zhang C, Boini KM, Thacker AM, and Li PL. Membrane raft-lysosome redox signalling platforms in coronary endothelial dysfunction induced by adipokine visfatin. Cardiovasc Res 89: 401-409, 2011.
47. Yi F, Jin S, Zhang F, Xia M, Bao JX, Hu J, Poklis JL, and Li PL. Formation of lipid raft redox signalling platforms in glomerular endothelial cells: an early event of homocysteine- induced glomerular injury. J Cell Mol Med 13: 3303-3314, 2009.
48. Yi F, Xia M, Li N, Zhang C, Tang L, and Li PL. Contribution of guanine nucleotide exchange factor Vav2 to hyperhomocysteinemic glomerulosclerosis in rats. Hypertension 53: 90-96, 2009.
49. Yi F, Zhang AY, Janscha JL, Li PL, and Zou AP. Homocysteine activates NADH/NADPH oxidase through ceramide- stimulated Rac GTPase activity in rat mesangial cells. Kidney Int 66: 1977-1987, 2004.
50. Yi F, Zhang AY, Li N, Muh RW, Fillet M, Renert AF, and Li PL. Inhibition of ceramide-redox signaling pathway blocks glomerular injury in hyperhomocysteinemic rats. Kidney Int 70: 88-96, 2006.
51. Zhang AY, Yi F, Jin S, Xia M, Chen QZ, Gulbins E, and Li PL. Acid sphingomyelinase and its redox amplification in formation of lipid raft redox signaling platforms in endothelial cells. Antioxid Redox Signal 9: 817-828, 2007.
52. Zhang C, Hu JJ, Xia M, Boini KM, Brimson C, and Li PL. Redox signaling via lipid raft clustering in homocysteineinduced injury of podocytes. Biochim Biophys Acta 1803: 482-491, 2010.
53. Zhang C, Hu JJ, Xia M, Boini KM, Brimson CA, Laperle LA, and Li PL. Protection of podocytes from hyperhomocysteinemia- induced injury by deletion of the gp91phox gene. Free Radic Biol Med 48: 1109-1117, 2010.
54. Zhang DX, Yi FX, Zou AP, and Li PL. Role of ceramide in TNF-alpha-induced impairment of endothelium-dependent vasorelaxation in coronary arteries. Am J Physiol Heart Circ Physiol 283: H1785-H1794, 2002.
55. Zhang Y, Li X, Carpinteiro A, Goettel JA, Soddemann M, and Gulbins E. Kinase suppressor of Ras-1 protects against pulmonary Pseudomonas aeruginosa infections. Nat Med 17: 341-346, 2011.
56. Zhang Y, Sauler M, Shinn AS, Gong H, Haslip M, Shan P, Mannam P, and Lee PJ. Endothelial PINK1 mediates the protective effects of NLRP3 deficiency during lethal oxidant injury. J Immunol 192: 5296-5304, 2014.
57. Zheng Y, Gardner SE, and Clarke MC. Cell death, damageassociated molecular patterns, and sterile inflammation in cardiovascular disease. Arterioscler Thromb Vasc Biol 31: 2781-2786, 2011.
58. Zhou R, Tardivel A, Thorens B, Choi I, and Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 11: 136-140, 2010.